Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 1Classical hematology 1

Conditions

Multiple Myeloma 1Anemia, Sickle Cell 1

Interventions

avatrombopag 5iron isomaltoside 1000 4hetrombopag 3ferric carboxymaltose 3Cytarabine 3eltrombopag 2Rivaroxaban 2Radiotherapy 2Meropenem 2Idarubicin 2Granulocyte Colony-Stimulating Factor 2Etoposide 2Erythropoietin 2Cyclophosphamide 2Azacitidine 2thymoglobulin 1stinging nettle lectin 1romiplostim 1raltitrexed 1peppermint oil 1pegfilgrastim 1oprelvekin 1fludarabine phosphate 1fludarabine 1ferrous succinate 1ferrous fumarate 1ferric derisomaltose 1epoetin beta 1cc-486 1Vitamin B 12 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Protease Inhibitors × Classical hematology × Clear all
NCT03535220 2018-05-24

The American Society of Hematology (ASH) Research Registry: A Multicenter Research Registry of Patients With Hematologic Disease

American Society of Hematology

Unknown
20,000 enrolled
Classical hematologyPlasma cell

Anemia, Sickle Cell, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡